相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lipoprotein(a): a genetic marker for cardiovascular disease and target for emerging therapies
Arturo Cesaro et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2021)
Pemafibrate decreases triglycerides and small, dense LDL, but increases LDL-C depending on baseline triglycerides and LDL-C in type 2 diabetes patients with hypertriglyceridemia: an observational study
Ichiro Komiya et al.
LIPIDS IN HEALTH AND DISEASE (2021)
Legacy effect of fibrate add-on therapy in diabetic patients with dyslipidemia: a secondary analysis of the ACCORDION study
Lin Zhu et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics
William E. Boden et al.
EUROPEAN HEART JOURNAL (2020)
Association between the Non-high-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio and the Risk of Coronary Artery Disease
Jiayin You et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease
Brian A. Ference et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials
Nicholas A. Marston et al.
CIRCULATION (2019)
Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα): Pooled Analysis of Phase 2 and 3 Studies in Dyslipidemic Patients with or without Statin Combination
Shizuya Yamashita et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Non-HDL as a Valid Surrogate Marker of Small Dense LDL in a Young Indian Population
Anjali Manocha et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2019)
Small dense low-density lipoprotein cholesterol is a promising biomarker for secondary prevention in older men with stable coronary artery disease
Koshiro Sakai et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2018)
Pathophysiology of Diabetic Dyslipidemia
Tsutomu Hirano
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2018)
Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
Aruna D. Pradhan et al.
AMERICAN HEART JOURNAL (2018)
Homogeneous Assays for LDL-C and HDL-C are Reliable in Both the Postprandial and Fasting State
Takashi Miida et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2017)
Effect of ezetimibe add-on therapy over 52 weeks extension analysis of prospective randomized trial (RESEARCH study) in type 2 diabetes subjects
Kentaro Sakamoto et al.
LIPIDS IN HEALTH AND DISEASE (2017)
Method for estimating high sdLDL-C by measuring triglyceride and apolipoprotein B levels
Toshiyuki Hayashi et al.
LIPIDS IN HEALTH AND DISEASE (2017)
Pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor alpha modulator for management of atherogenic dyslipidaemia
Jean-Charles Fruchart
CARDIOVASCULAR DIABETOLOGY (2017)
Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial
Shun Ishibashi et al.
ATHEROSCLEROSIS (2016)
The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity
Jan Boren et al.
CURRENT OPINION IN LIPIDOLOGY (2016)
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Alberico L. Catapano et al.
EUROPEAN HEART JOURNAL (2016)
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions A Systematic Review and Meta-analysis
Michael G. Silverman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Non-HDL Cholesterol is a More Superior Predictor of Small-Dense LDL Cholesterol than LDL Cholesterol in Japanese Subjects with TG Levels <400 mg/dL
Kengo Moriyama et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2016)
Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies
Parag H. Joshi et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Determinants of Bezafibrate-induced Improvements in LDL Cholesterol in Dyslipidemic Patients with Diabetes A Subgroup Analysis of the J-BENEFIT Study
Takahisa Hirose et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2015)
Small Dense Low-Density Lipoprotein-Cholesterol Concentrations Predict Risk for Coronary Heart Disease The Atherosclerosis Risk in Communities ( ARIC) Study
Ron C. Hoogeveen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group
Michel R. Langlois et al.
ATHEROSCLEROSIS (2014)
Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: Effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size
Shigemasa Tani et al.
JOURNAL OF CARDIOLOGY (2014)
LDL-Migration Index (LDL-MI), an Indicator of Small Dense Low-Density Lipoprotein (sdLDL), Is Higher in Non-Alcoholic Steatohepatitis than in Non-Alcoholic Fatty Liver: A Multicenter Cross-Sectional Study
Kento Imajo et al.
PLOS ONE (2014)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
A multicenter study on the precision and accuracy of homogeneous assays for LDL-cholesterol: Comparison with a beta-quantification method using fresh serum obtained from non-diseased and diseased subjects
Takashi Miida et al.
ATHEROSCLEROSIS (2012)
Basal and Insulin Mediated VLDL-Triglyceride Kinetics in Type 2 Diabetic Men
Lars P. Sorensen et al.
DIABETES (2011)
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
M. John Chapman et al.
EUROPEAN HEART JOURNAL (2011)
Seven Direct Methods for Measuring HDL and LDL Cholesterol Compared with Ultracentrifugation Reference Measurement Procedures
W. Greg Miller et al.
CLINICAL CHEMISTRY (2010)
Association between Non-High-Density Lipoprotein Cholesterol Concentrations and Mortality from Coronary Heart Disease Among Japanese Men and Women: The Ibaraki Prefectural Health Study
Hiroyuki Noda et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2010)
The ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus.
Lukasz Januszkiewicz
KARDIOLOGIA POLSKA (2010)
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
Henry N. Ginsberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Meta-Analysis of the Relationship Between Non-High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk
Jennifer G. Robinson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment
John J. P. Kastelein et al.
CIRCULATION (2008)
Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial
Michael Miller et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Relationship between lipid abnormalities and insulin resistance in Japanese school children
Yoshihide Asato et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men
T Pischon et al.
CIRCULATION (2005)
Use of metabolic markers to identify overweight individuals who are insulin resistant
T McLaughlin et al.
ANNALS OF INTERNAL MEDICINE (2003)
分享论文
